Article Figures & Data
Figures
- Figure 1
CONSORT flow diagram for study population. AIS, Abbreviated Injury Scale; GCS, Glasgow Coma Scale.
- Figure 2
Least square means (±SE) plot of heart rate (beats per minute) comparing the treatment group (propranolol) to control. *Indicates difference between groups with p<0.05.
- Figure 3
Least square means (±SE) plot. Mean arterial pressure (mm Hg) comparing the treatment group (propranolol) to control. *Indicates difference between groups with p<0.05.
- Figure 4
Least square means (±SE) plot of Glasgow Coma Scale score comparing the treatment group (propranolol) to control. *Indicates difference between groups with p<0.05.
- Figure 5
Kaplan-Meier survival analysis. Treatment=propranolol group. No difference between groups with p=0.708.
- Figure 6
Least square means (±SE) of total urinary catecholamines (μg/L) comparing the treatment group (propranolol) to control.
Tables
- Table 1
Descriptive statistics comparing PRO to the control group
Total study PRO Control P value n=25 n=13 n=12 Age (years) 51.3 (±20.1) 49.7 (±19.0) 53.0 (±21.9) 0.689 Female 36.0% 30.8% 41.7% 0.688 Caucasian 60.0% 61.5% 58.3% 0.999 Blunt 88.0% 84.6% 91.7% 0.999 ISS 21.8 (±5.0) 21.9 (±4.2) 21.8 (±5.5) 0.965 Head AIS 4 (3, 4) 3 (3, 4) 4 (3, 4) 0.611 LOS (days) 32.6 (±37.5) 30.7 (±12.0) 34.8 (±53.9) 0.799 ICU LOS (days) 16.0 (±6.9) 16.3 (±7.1) 15.7 (±6.9) 0.821 Admit BD (meq/L) −3.6 (±3.9) −4.8 (±2.6) −2.4 (±4.7) 0.132 Admit lactate (mmol/L) 2.5 (±1.7) 2.2 (±1.3) 2.8 (±2.1) 0.371 Charlson Index 1 (0, 2) 1 (0, 2) 2 (0.5, 3.5) 0.351 Transfusions (units) 0 (0, 1) 0 (0, 2) 0 (0, 0) 0.389 Ventilator days 13.4 (±6.2) 13.4 (±6.3) 13.5 (±6.3) 0.964 Mortality 20.0% 7.7% 33.3% 0.109 Categorical variables expressed as percentages. Continuous variables expressed at mean (±SD) or median (IQR).
AIS, Abbreviated Injury Scale; BD, base deficit; ICU LOS, intensive care unit length of stay; ISS, Injury Severity Score; LOS, length of stay; PRO, propranolol; SBP, systolic blood pressure.
Supplementary data
Supplementary data
Supplementary data
